Parkinson’s disease (PD) is the 2nd most common neurodegenerative disorder, affecting greater than 1% of people over 60. As occurrences are predicted to double in the next 20 years, there is a critical need for the development of prophylactic and/or therapeutic interventions. We have recently identified two enzymes, USP8 and AMPK, that interact and may […]
Read More